Roflumilast in Dermatology: A Newer Phosphodiesterase-4 Inhibitor

Roflumilast in Dermatology: A Newer Phosphodiesterase-4 Inhibitor

Saved in:

Bibliographic Details
Main Authors:	Suvesh Singh, Debopriya Paul, Aditi Snehal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-01-01
Series:	Indian Journal of Dermatology
Online Access:	https://journals.lww.com/10.4103/ijd.ijd_261_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
by: Elena Carmona-Rocha, et al.
Published: (2025-01-01)

Newer Hemostatic Agents Used in the Practice of Dermatologic Surgery
by: Jill Henley, et al.
Published: (2013-01-01)

The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor
by: Suzuki Osamu, et al.
Published: (2015-06-01)

Phosphodiesterase-5 inhibitors: Raynaud's and beyond
by: Sanat Phatak, et al.
Published: (2017-01-01)

Purin-6-One Derivatives as Phosphodiesterase-2 Inhibitors
by: Wei Yuan, et al.
Published: (2016-01-01)

Therapeutic effects of mirodenafil, a phosphodiesterase 5 inhibitor, on stroke models in rats
by: Fred Kim, et al.
Published: (2025-01-01)

Neurodermatitis of the scalp associated with trichotillomania treated with roflumilast cream 0.3%
by: Edith Hanna, MD, et al.
Published: (2025-02-01)

Phosphodiesterase 4 inhibition as a novel treatment for stroke
by: Jiahong Zhong, et al.
Published: (2025-01-01)

Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
by: Christina Alves Peixoto, et al.
Published: (2015-01-01)

Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
by: Tariq F. Al-Shaiji, et al.
Published: (2009-01-01)

Future Uses of Newer Macrolides
by: John Segreti
Published: (1993-01-01)

Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management
by: Aris Kaltsas, et al.
Published: (2025-01-01)

Synthesis and Antimicrobial Activity of Newer Quinazolinones
by: J. A. Patel, et al.
Published: (2006-01-01)

TONGUE—A NEWER BIOMETRIC: An Observational Study
by: Vishnu Rajendran, et al.
Published: (2024-12-01)

Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
by: Xiaofang Yu, et al.
Published: (2018-01-01)

Newer Root Canal Irrigants in Horizon: A Review
by: Sushma Jaju, et al.
Published: (2011-01-01)

Rapid Screening and Quantitative Determination of Illegal Phosphodiesterase Type 5 Inhibitors (PDE-5i) in Herbal Dietary Supplements
by: Thi Oanh Nguyen, et al.
Published: (2021-01-01)

Overview of Newer Glucocorticosteroid Preparations for Inflammatory Bowel Disease
by: R Brattsand
Published: (1990-01-01)

Current Controversies in Newer Therapies to Treat Birth Asphyxia
by: Pia Wintermark
Published: (2011-01-01)

The Use of Newer High Translucency Zirconia in Aesthetic Zone
by: Zishan Dangra, et al.
Published: (2014-01-01)

Mechanisms of L-citrulline on phosphodiesterase 5 in erectile dysfunction intervention
by: Abdulhakeem Olarewaju Sulyman, et al.
Published: (2025-03-01)

A Computational Approach towards the Development of Newer Anticancer Agents
by: Javed I. Sheikh, et al.
Published: (2010-01-01)

Dermatology /
by: Falco, Braun O. et..al
Published: (1991)

Investigating the Quality of DermaMNIST and Fitzpatrick17k Dermatological Image Datasets
by: Kumar Abhishek, et al.
Published: (2025-02-01)

Erratum: JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
Published: (2025-01-01)

Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system
by: Federica Campolo, et al.
Published: (2025-01-01)

Dermatology : Lecture Notes /
by: Brown, Robin Graham
Published: (2011)

Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients
by: Ehab Mudher Mikhael
Published: (2016-01-01)

Navaratnas in Dermatology
by: Ilangovane Soumiya, et al.
Published: (2025-01-01)

The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating Levels of Inflammatory Biomarkers in Patients with Psoriatic Arthritis: Substudy Results from a Phase III, Randomized, Placebo-Controlled Trial (PALACE 1)
by: Peter H. Schafer, et al.
Published: (2015-01-01)

Repurposing of phosphodiesterase-5 inhibitor sildenafil as a therapeutic agent to prevent gastric cancer growth through suppressing c-MYC stability for IL-6 transcription
by: Zhenzhan Zhang, et al.
Published: (2025-01-01)

Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management
by: Giovanni Paolino, et al.
Published: (2025-01-01)

Atlas of Clinical Dermatology /
by: Du Vivier, Anthony
Published: (1993)

Buka's Emergencies in Dermatology /
by: Buka, Bobby
Published: (2013)

Why do newer degrees of freedom appear in higher-order truncated hydrodynamic theory?
by: Sukanya Mitra
Published: (2025-01-01)

Newer Generation of Scooters: Polychlorinated Dibenzo-p-dioxin and Dibenzofuran and Polychlorinated Biphenyl Reductions
by: Hung-Hong Chen, et al.
Published: (2020-05-01)

Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis
by: Ragia Hegazy, et al.
Published: (2011-01-01)

Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis
by: P. Priyanka, et al.
Published: (2018-01-01)

Newer Clinical Strategies for Combining Interferon and Cytotoxic Agents Against Solid Tumours and Hematological Malignancies
by: Scott Wadler
Published: (1994-01-01)

Synthesis and Study of Some Newer Analogues ofQuinolin-8-ol as Potent Antimicrobial Agents
by: Jyoti Sharma, et al.
Published: (2008-01-01)